Antidepressant-like effect of folic acid: Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway

European Journal of Pharmacology

Volumn 598, Issue 1-3, 2008, Pages 37-42

  Brocardo, Patrícia de Souza ^a   Budni, Josiane ^a   Lobato, Kelly Ribas ^a   Kaster, Manuella Pinto ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antidepressant; Folic acid; Forced swimming test; l arginine nitric oxide cGMP pathway

Indexed keywords

7 NITROINDAZOLE; ARGININE; CYCLIC GMP; FOLIC ACID; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; SILDENAFIL;

ANIMAL EXPERIMENT; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FORCED SWIMMING TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; CYCLIC GMP; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; FEMALE; FOLIC ACID; INDAZOLES; INJECTIONS, INTRAVENTRICULAR; MALE; METHYLENE BLUE; MICE; N-METHYLASPARTATE; NITRIC OXIDE; NITRIC OXIDE DONORS; RECEPTORS, N-METHYL-D-ASPARTATE; S-NITROSO-N-ACETYLPENICILLAMINE; SIGNAL TRANSDUCTION; SWIMMING; VITAMIN B COMPLEX;

EID: 54049141605     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.033     Document Type: Article

References (41)

1. Abou-Saleh M.T., and Coppen A. Folic acid and the treatment of depression. J. Psychosom. Res. 61 (2006) 285-287
2. Almeida R.C., Felisbino C.S., López M.G., Rodrigues A.L.S., and Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav. Brain Res. 168 (2006) 318-322
3. Alpert J.E., Mischoulon D., Rubenstein G.E., Bottonari K., Nierenberg A.A., and Fava M. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann. Clin. Psychiatry 14 (2002) 33-38
4. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75 (1995) 725-748
5. Bonanno G., Giambelli R., Raiteri L., Tiraboschi E., Zappettini S., Musazzi L., Raiteri M., Racagni G., and Popoli M. Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J. Neurosci. 25 (2005) 3270-3279
6. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-160
7. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 (2005) 1103-1112
8. Boyer P.A., Skolnick P., and Fossom L.H. Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study. J. Mol. Neurosci. 10 (1998) 219-233
9. Brocardo P.S., Budni J., Kaster M.P., Santos A.R.S., and Rodrigues A.L.S. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 54 (2008) 464-473
10. Coppen A., Bailey J., and Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J. Affect. Disord. 60 (2000) 121-130
11. Coppen A., and Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J. Psychopharmacol. 19 (2005) 59-65
12. Da Silva G.D., Matteussi A.S., Santos A.R.S., Calixto J.B., and Rodrigues A.L.S. Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. NeuroReport 11 (2000) 3699-3702
13. Denninger J.W., and Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta. 1411 (1999) 334-350
14. Dhir A., and Kulkarni S.K. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur. J. Pharmacol. 568 (2007) 177-185
15. Ergün Y., and Ergün U.G. Prevention of pro-depressant effect of l-arginine in the forced swim test by NG-nitro-l-arginine and [1H-[1,2,4]Oxadiazole[4,3-a]quinoxalin-1-one]. Eur. J. Pharmacol. 554 (2007) 150-154
16. Eroglu L., and Caglayan B. Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol. Res. 36 (1997) 381-385
17. Esplugues J.V. NO as a signalling molecule in the nervous system. Brit. J. Pharmacol. 135 (2002) 1079-1095
18. Forray M.I., Bustos G., and Gysling K. Noradrenaline inhibits glutamate release in the rat bed nucleus of the stria terminalis: In vivo microdialysis studies. J. Neurosci. Res. 55 (1999) 311-320
19. Godfrey P.S., Toone B.K., Carney M.W., Flynn T.G., Bottiglieri T., Laundy M., Chanarin I., and Reynolds E.H. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336 (1990) 392-395
20. Harkin A.J., Bruce K.H., Craft B., and Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 372 (1999) 207-213
21. Harkin A., Connor T.J., Walsh M., St John N., Kelly J.P., Connor T.J., Walsh M., St John N., and Kelly J.P. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 44 (2003) 616-623
22. Harkin A.J., Connor T.J., Burns M.P., and Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin reuptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 14 (2004) 274-281
23. Heiberg I.L., Wegener G., and Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain Res. 134 (2002) 479-484
24. Joca S.R., and Guimarães F.S. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 185 (2006) 298-305
25. Karolewicz B., Paul I.A., and Antkiewicz-Michaluk L. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Pol. J. Pharmacol. 53 (2001) 587-596
26. Kaster M.P., Rosa A.O., Santos A.R.S., and Rodrigues A.L.S. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int. J. Neuropsychopharmacol. 8 (2005) 601-606
27. Kulkarni S.K., and Dhir A. Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur. J. Pharmacol. 569 (2007) 77-83
28. Maura G., Marcoli M., Pepicelli O., Rosu C., Viola C., and Raiteri M. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT2C and 5-HT1A receptors. Br. J. Pharmacol. 130 (2000) 1853-1858
29. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 (1997) 1436-1442
30. Paul I.A., Skolnick P., and Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann. N. Y. Acad. Sci. 1003 (2003) 250-272
31. Paul I.A., Nowak G., Layer R.T., Popik P., and Skolnick P. Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther. 269 (1994) 95-102
32. Pittaluga A., Raiteri L., Longordo F., Luccini E., Barbiero V.S., Racagni G., Popoli M., and Raiteri M. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology 53 (2007) 27-36
33. Rosa A.O., Lin J., Calixto J.B., Santos A.R.S., and Rodrigues A.L.S. Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav. Brain Res. 144 (2003) 87-93
34. Skolnick P. Antidepressants for the new millennium. Eur. J. Pharmacol. 375 (1999) 31-40
35. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters. Science 257 (1992) 494-496
36. Szasz B.K., Mike A., Karoly R., Gerevich Z., Illes P., Vizi E.S., and Kiss J.P. Direct inhibitory effect of fluoxetine on N-methyl-d-aspartate receptors in the central nervous system. Biol. Psychiatry 62 (2007) 1303-1309
37. Travagli A.R., and Williams J.T. Endogenous monoamines inhibit glutamate transmission in the spinal trigeminal nucleus of the guinea-pig. J. Physiol. 491 (1996) 177-185
38. Volke V., Wegener G., Bourin M., and Vasar E. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav. Brain Res. 140 (2003) 141-147
39. Wegener G., Volke V., Harvey B.H., and Rosenberg R. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res. 959 (2003) 128-134
40. Yildiz F., Erden B.F., Ulak G., Utkan T., and Gacar N. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology 149 (2000) 41-44
41. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., and Manji H.K.A. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63 (2006) 856-864